Ziying Wang

Ziying Wang

Auto-generated profile, based on publicly available information

Ziying Wang

State Key Laboratory of Medical Neurobiology and MOE Frontiers Center for Brain Science, Huashan Hospital, School of Life Sciences, Fudan University

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 August 2021 in Acta Pharmacologica Sinica
Verified
Journal Article
Open access
PDF file
CYChuanbin Yang
Chuanbin Yang
JLJia Liu
Jia Liu
BTBenjamin Chun-Kit TONG
Benjamin Chun-Kit TONG
ZWZi-Ying Wang
Zi-Ying Wang
ZZZHOU ZHU
ZHOU ZHU
MLMin LI
Min LI
Transcriptional factor EB (TFEB), a master regulator of autophagy and lysosomal biogenesis, is generally regarded as a pro-survival factor. Here, we identify that besides its effect on autophagy induction, TFEB exerts a pro-apoptotic effect in response to the cyclopentenone prostaglandin 15-deoxy-∆-12,14-prostaglandin J2 (15d-PGJ2). Specifically, 15d-PGJ2 promotes TFEB translocation from the cytoplasm into the nucleus to induce autophagy and lysosome biogenesis via reactive oxygen species (ROS) production rather than mTORC1 inactivation. Surprisingly, TFEB promotes rather than inhibits apoptosis in response to 15d-PGJ2. Mechanistically, ROS-mediated TFEB translocation into the nucleus transcriptionally upregulates the expression of ATF4, which is required for apoptosis elicited by 15d-PGJ2. Additionally, inhibition of TFEB activation by ROS scavenger N-acetyl cysteine or inhibition of protein synthesis by cycloheximide effectively compromises ATF4 upregulation and apoptosis in response to 15d-PGJ2. Collectively, these results indicate that ROS-induced TFEB activation exerts a novel role in promoting apoptosis besides its role in regulating autophagy in response to 15d-PGJ2. This work not only evidences how TFEB is activated by 15d-PGJ2, but also unveils a previously unexplored role of ROS-dependent activation of TFEB in modulating cell apoptosis in response to 15d-PGJ2.

25 September 2021 in Protein Science
Verified
Journal Article
Closed access
PDF file
ZWZiying Wang
Ziying Wang
LLLong Li
Long Li
RHRongting Hu
Rongting Hu
PZPeiyu Zhong
Peiyu Zhong
YZYiran Zhang
Yiran Zhang
Yu DingYu Ding
Yu Ding

8 March 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
CZChao Zhong
Chao Zhong
ZWZiying Wang
Ziying Wang
ZLZhaoyang Li
Zhaoyang Li
HLHaofeng Li
Haofeng Li
QXQianhui Xu
Qianhui Xu
BLBoxun Lu
Boxun Lu
In the recent issue of Nature Communications (2023 Nov 30;14(1):7908), Xue et. al. reported a very interesting and significant discovery of a possible DCAF11 ligand chemotype that could be used as the “warhead” to design bifunctional compounds for targeted degradation via engaging the E3 ligase DCAF11 1 (annotated as ref 1 hereafter). The discovery is of importance to the targeted protein degradation field and was inspired by previous reports suggesting that similar compounds may also engage the autophagosome protein LC3 for degradation and function as autophagy-tethering compounds (ATTECs) 2, 3, 4, 5, 6, 7 , which seem to be inconsistent with ref 1. We think that the conclusions based on these data are not necessarily mutually exclusive. After performing additional experiments and analyses, we would like to discuss some possibilities explaining such discrepancies and make a few points of clarification.